India-Canada face-off: Adverse impact unlikely on pharma, says Pharmexcil DG ...Middle East

canadian news today - News
India-Canada face-off: Adverse impact unlikely on pharma, says Pharmexcil DG
The diplomatic stand-off between India and Canada is unlikely to have any impact on the pharmaceutical exports, according to R Uday Bhaskar, Director-General, Pharmaceutical Export Promotion Council. “Going by the current state of affairs, I do not think any adverse impact is possible. Canada is the second biggest market in North America after the US for pharma exports and therefore, it is an important geography for our pharma industry,’‘ he told businessline. Growing exports Indian pharma exports to Canada grew 21 percent at $506 million in FY23 compared to the previous financial year. During the April-July period In the current financial year, the exports stood at $149 million, accordi

Hence then, the article about india canada face off adverse impact unlikely on pharma says pharmexcil dg was published today ( ) and is available on canadian news today ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( India-Canada face-off: Adverse impact unlikely on pharma, says Pharmexcil DG )

Apple Storegoogle play

Last updated :

Also on site :